Georgia Healthcare Group PLC (“GHG” or the “Group” – LSE: GHG LN), announces the Group’s first quarter 2020 consolidated financial results. Unless otherwise mentioned, comparatives are for the first quarter of 2019. The results are based on International Financial Reporting Standards (“IFRS”) as adopted in the European Union (“EU”), are unaudited and extracted from management accounts.
GHG announces today the Group’s 1Q20 consolidated results, reporting 10.6% y-o-y growth in revenues to GEL 260.1 million (US$79.2 million/GBP 63.9 million) and a 50 basis point reduction in ROIC. The Group posted near break-even profit of GEL 0.1 million, excluding the IFRS 16 lease accounting impact. The Group’s adjusted profit and EPS in 1Q20 totalled GEL 14.3 million (US$4.4 million/GBP 3.5 million) and GEL 0.07 (US$0.02 per share/GBP 0.02 per share) respectively, both excluding IFRS 16 impact.
